NCT06572306 - Pharmacist-led Continuous Glucose Monitoring | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 5, 2025

Study Completion Date

August 5, 2025

Conditions

Type 2 Diabetes

Interventions

DEVICE

FreeStyle Libre 2 Continuous Glucose Monitor

Subjects included in the intervention group (continuous glucose monitoring) will be recruited from the USF Health Department of Family Medicine. Each subject will be enrolled for 12 weeks.

Trial Locations (2)

33612

RECRUITING

USF Health Department of Family Medicine - Morsani Center for Advanced Health Care, Tampa

33613

RECRUITING

USF Health Department of Family Medicine - University Partnership Center, Tampa

All Listed Sponsors

lead

University of South Florida

OTHER